Advertisement

Surgery General

Implications of radiofrequency ablation in patients undergoing thyroid surgery for benign disease in the United States.

Jul 29, 2021

Radiofrequency ablation is an alternative strategy for the management of benign thyroid conditions. We analyzed the proportion of patients who underwent thyroid surgery for benign conditions who would...

The Impact of Simulation Based Training on the Fundamentals of Endoscopic Surgery Performance Examination.

Jul 29, 2021

To determine if simulation training is required to pass the Fundamentals of Endoscopic Surgery (FES) skills test and assess the relationship between simulation training, clinical training, and FES ski...

Characterization of academic cardiothoracic surgeons who started as attendings in private or community practice.

Jul 29, 2021

Surgeons are traditionally categorized as working either in academic or private/community practice, but some transition between the two environments. Here, we profile current academic cardiothoracic s...

Durability of CNS disease control in NSCLC patients

Jul 28, 2021

This study states that The activity of immune checkpoint inhibitors (ICI) against NSCLC brain metastases is unknown. We compared CNS outcomes between ICI- and chemo-treated patients who have received...

Platinum-doublet chemotherapy

Jul 28, 2021

his study states that Optimal second-line chemotherapy for patients with relapsed small-cell lung cancer remains debatable. In addition to topotecan or amrubicin monotherapy, re-challenge with first-l...

Monitoring levels of vimentin-positive

Jul 28, 2021

This study states that Circulating tumor cells (CTCs) are associated with tumor spread, whereas cancer stem cells may be related to drug resistance. However, few studies have analyzed the levels of ci...

Real-world outcomes of immunotherapy

Jul 28, 2021

This study states that First-line (1L) immunotherapy (I-O) has improved outcomes in patients with advanced non-small cell lung cancer (NSCLC) in clinical trials and is now routinely used alone or comb...

Selection of individuals for lung cancer screening

Jul 28, 2021

This study clearly depicts that Lung cancer screening eligibility determined by Health Technology Assessment (HTA) and MISCAN microsimulation model vs. PLCOm2012 model. PLCOm2012 had significantly hig...

Evaluation of disease staging

Jul 28, 2021

This study states that Despite extensive effort, the search for clinically-relevant metabolite biomarkers for early detection, disease monitoring, and outcome prediction in lung cancer remains unfulfi...

Prognostic factors in patients

Jul 28, 2021

Limited information is available on the appropriate treatment duration of immune checkpoint inhibitors (ICIs). We aimed to identify candidates who would benefit from ICI discontinuation after one year...

Microsimulation modeling of extended

Jul 28, 2021

The aim is To microsimulate the effects of three additional annual CT screening rounds on lung cancer (LC) survival in the National Lung Screening Trial (NLST). We used multiple imputation to model t...

Impact of COVID-19 on the management of patients

Jul 28, 2021

Our study provides a unique insight in the decision making in the setting of COVID-19 outbreak. A treatment strategy modification after COVID-19 outbreak was made for 32 % of patients. Treatment modif...

Rates of invasive disease and outcomes

Jul 28, 2021

The aim of this study is For NSCLC with biopsy suggestive of in situ disease, 49.3 % had invasion at resection.Size and squamous histology were significantly associated with risk of invasion. Even les...

Lymph Node Dissection in Thymoma

Jul 28, 2021

The incidence of lymph node metastases in thymoma remains unclear. Surgical complications of lymph node dissection are rare. Systematic lymph node dissection did not increase the rate of N positive tu...

Thromboembolism in ALK+ and ROS1+ NSCLC patients

Jul 28, 2021

It is well known that there is an increased incidence of thromboembolism (TE) in association with cancer including non-small cell lung cancer [[1],[2]]. Recently, a number of publications have reporte...

Type II endoleak and aortic aneurysm

Jul 28, 2021

In this study we focus on Type II endoleak (T2EL) is the most well-known endoleak after endovascular aneurysm fix (EVAR). Its ideal administration has been dubiously talked about. In this way, starter...

Onyx versus coil embolization

Jul 28, 2021

This study aims on the Little evidence is available supporting the optimal treatment of type II endoleaks associated with aortic sac growth. Previous studies have lacked comparisons between treatment ...

Long-term failure after endovascular aneurysm

Jul 28, 2021

This study states that Endovascular aneurysm fixing (EVAS) is a creative option to regular endovascular aneurysm fix (EVAR). EVAS depends on sac securing without proximal obsession to accomplish fixin...

Early and midterm outcomes of endovascular

Jul 28, 2021

In this study we have  evaluated the early and midterm outcomes of the Incraft (Cordis Corp, Bridgewater, NJ) ultra-low-profile endograft by analyzing data from the Triveneto Incraft Registry (TIR). ...

Long-term chimney/snorkel endovascular aortic

Jul 28, 2021

The early and short-term efficacy of the snorkel/chimney technique for endovascular aortic aneurysm repair (ch-EVAR) have been previously reported. However, long-term ch-EVAR performance, vessel paten...

SUBSPECIALTIES

Advertisement